Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Doublebase Once is a once-daily, highly moisturizing emollient gel developed by Dermal Laboratories for the management of dry skin conditions such as atopic dermatitis (eczema), psoriasis, and ichthyosis. The formulation contains emollient oils, including isopropyl myristate and liquid paraffin, which create a protective barrier on the skin surface to prevent transepidermal water loss. It also incorporates the humectant glycerol, which actively attracts and retains moisture within the stratum corneum. This combination provides sustained hydration for up to 24 hours from a single application. Doublebase Once is designed to be free from common irritants such as steroids, fragrances, parabens, sodium lauryl sulfate (SLS), and methylisothiazolinone (MI) preservatives, making it suitable for patients of all ages. It can be used both as a leave-on moisturizer and as a soap substitute to minimize skin irritation during washing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Doublebase Once.